<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">

  <title>NICE Formulary - METRONIDAZOLE</title>

  <meta name="X-UA-Compatible" content="IE=edge,chrome=1">
  <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0">
  <meta name="description" content="">
  <meta name="author" content="NICE - The National Institute of Health and Care Excellence">

  <!--[if lt IE 9]>
  <script src="http://mattonfoot.github.io/NICE.UI/scripts/vendor/html5shiv.js"></script>
  <![endif]-->

  <!-- Le styles -->
  <link rel="stylesheet" href="http://mattonfoot.github.io/NICE.UI/styles/ui.css">

  <!-- Fav and touch icons -->
  <link rel="shortcut icon" href="http://cdn.nice.org.uk/V3/Content/nice/favicon.ico">
  <link rel="apple-touch-icon-precomposed" href="http://cdn.nice.org.uk/V3/Content/nice/favicon-152.png">
  <meta name="msapplication-TileColor" content="#fafafb">
  <meta name="msapplication-TileImage" content="http://cdn.nice.org.uk/V3/Content/nice/favicon-144.png">

  <style>
  .tab-content {
    overflow: auto;
  }
  .tab-content > .tab-pane {
    display: none;
  }
  .tab-content > .active {
    display: block;
  }

  header .nav {
    list-style: decimal inside none;
  }
  header .nav > li {
    display: list-item;
  }
  header .nav > li > a {
    display: block;
    margin: 0;
    padding: 0;
    text-decoration: none;
    color: #01769d;
  }
  header .nav > li > a:hover,
  header .nav > li > a:focus,
  header .nav > li.active > a,
  header .nav > li.active > a:hover,
  header .nav > li.active > a:focus {
    outline: 0;
    color: #08455b;
    background: transparent;
    text-decoration: none;
  }
  header .nav > li > a:hover,
  header .nav > li > a:focus {
    text-decoration: underline;
  }

  [outputclass="title"],
  .title {
    font-size: 19px;
    font-size: 1.9rem;
    line-height: 24px;
    line-height: 2.4rem;
  }

  h3, h4, h5, h6, .title, [outputclass="title"] {
    margin-bottom: 0;
  }

  h1+p, h2+p, h3+p, h4+p, h5+p, h6+p, .title+p, [outputclass="title"]+p {
    margin-top: 0;
  }

  .doses {
    padding-left: 0;
    list-style: none;
  }
  .doses .dose {
    padding-left: 24px;
    padding-left: 2.4rem;
    margin-bottom: 6px;
    margin-bottom: .6rem;
  }
  .doses .adult {
    border-left: 7px solid #346e7f;
  }
  .doses .child {
    border-left: 7px solid #82176F;
  }

  /* DITA symbols */

  ph {
    color: #006;
  }

  tm::before {
    font-size: .8em;
    margin-left: -.2em;
    vertical-align: top;
  }
  tm[tmtype="reg"]::before {
    content: "\00ae";
  }
  tm[tmtype="copy"]::before {
    content: "\00a9";
  }
  tm[tmtype="trade"]::before {
    content: "\2122";
  }

  </style>
</head>

<body id="" class="">
  <header>
    <div class="container">
      <ul class="breadcrumb">
        <li><a href="../">Home</a> <span class="divider glyph-chevron-right"></span></li>
        <li class="active"><a href="../drug/">Drugs</a></li>
      </ul>

      <h1>METRONIDAZOLE</h1>


      <nav>
        <ul class="nav nav-list">

          <li class="active"><a href="#indicationsAndDoses" data-toggle="tab">Indications and doses</a></li>
          <li><a href="#drugAction" data-toggle="tab">Drug action</a></li>
          <li><a href="#pregnancy" data-toggle="tab">Pregnancy</a></li>
          <li><a href="#hepaticImpairment" data-toggle="tab">Hepatic impairment</a></li>
          <li><a href="#sideEffects" data-toggle="tab">Side effects</a></li>
          <li><a href="#directionsForAdministration" data-toggle="tab">Administration</a></li>
          <li><a href="#patientAndCarerAdvice" data-toggle="tab">Patient and carer advice</a></li>
          <li><a href="#cautions" data-toggle="tab">Cautions</a></li>
          <li><a href="#monitoringRequirements" data-toggle="tab">Monitoring requirements</a></li>
          <li><a href="#unlicensedUse" data-toggle="tab">Unlicensed use</a></li>
          <li><a href="#prescribingAndDispensingInformation" data-toggle="tab">Prescribing and dispensing</a></li>
          <li><a href="#professionSpecificInformation" data-toggle="tab">Profession specific information</a></li>
          <li><a href="#medicinalForms" data-toggle="tab">Medicinal forms</a></li>
        </ul>
      </nav>

      <br/>
    </div>
  </header>

  <div class="container">
    <div class="tab-content">

      <section class="tab-pane active" id="indicationsAndDoses">
        <h2>Indications and doses</h2>

        <section class="indicationAndDoseGroups">
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Anaerobic infections</span>,
            </h4>
            <p class="specificity"><span class="route">By intravenous infusion</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                400 mg every 8 hours, alternatively 500 mg every 8 hours usually treated for 7 days (for 10&#8211;14 days in Clostridium difficile infection).</li>
              <li class="dose adult"><strong>For adults </strong><br/>
                1 g 3 times a day for 3 days, then 1 g twice daily, for usual total treatment duration of 7 days.</li>
              <li class="dose adult"><strong>For adults </strong><br/>
                500 mg every 8 hours usually treated for 7 days (for 10&#8211;14 days in Clostridium difficile infection), to be given over 20 minutes.</li>
              <li class="dose child"><strong>For children 1 month</strong><br/>
                7.5 mg/kg every 12 hours usually treated for 7 days (for 10&#8211;14 days in Clostridium difficile infection).</li>
              <li class="dose child"><strong>For children 2 months&#8211;11 years</strong><br/>
                7.5 mg/kg every 8 hours (max. per dose 400 mg) usually treated for 7 days (for 10&#8211;14 days in Clostridium difficile infection).</li>
              <li class="dose child"><strong>For children 12&#8211;17 years</strong><br/>
                400 mg every 8 hours.</li>
              <li class="dose child"><strong>For children 1&#8211;11 months</strong><br/>
                125 mg 3 times a day for 3 days, then 125 mg twice daily, for usual total treatment duration of 7 days.</li>
              <li class="dose child"><strong>For children 1&#8211;4 years</strong><br/>
                250 mg 3 times a day for 3 days, then 250 mg twice daily, for usual total treatment duration of 7 days.</li>
              <li class="dose child"><strong>For children 5&#8211;9 years</strong><br/>
                500 mg 3 times a day for 3 days, then 500 mg twice daily, for usual total treatment duration of 7 days.</li>
              <li class="dose child"><strong>For children 10&#8211;17 years</strong><br/>
                1 g 3 times a day for 3 days, then 1 g twice daily, for usual total treatment duration of 7 days.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication"><ph outputclass="organism"> <i>Helicobacter pylori</i> </ph> eradication; in combination with clarithromycin and esomeprazole; or in combination with clarithromycin and lansoprazole; or in combination with amoxicillin and lansoprazole; or in combination with clarithromycin and omeprazole; or in combination with clarithromycin and pantoprazole; or in combination with clarithromycin and rabeprazole</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                400 mg twice daily.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication"><ph outputclass="organism"> <i>Helicobacter pylori</i> </ph> eradication; in combination with amoxicillin and omeprazole</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                400 mg 3 times a day.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication"><ph outputclass="organism"> <i>Helicobacter pylori</i> </ph> eradication failure (two-week regimen comprising a proton pump inhibitor plus tripotassium dicitratobismuthate plus tetracycline)</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                400&#8211;500 mg 3 times a day for 2 weeks.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Fistulating Crohn's disease</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                10&#8211;20 mg/kg daily in divided doses, usual dose 400&#8211;500 mg 3 times a day usually given for 1 month but no longer than 3 months because of concerns about peripheral neuropathy.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Leg ulcers and pressure sores</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                400 mg every 8 hours for 7 days.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Bacterial vaginosis (notably <ph outputclass="organism"> <i>Gardnerella vaginalis</i> </ph> infection)</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                400&#8211;500 mg twice daily for 5&#8211;7 days, alternatively 2 g for 1 dose.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Bacterial vaginosis</span>,
            </h4>
            <p class="specificity"><span class="route">By vagina using vaginal gel</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                1 applicatorful daily for 5 days, dose to be administered at night.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Pelvic inflammatory disease</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                400 mg twice daily for 14 days.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Acute ulcerative gingivitis</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                200&#8211;250 mg every 8 hours for 3 days.</li>
              <li class="dose child"><strong>For children 1&#8211;2 years</strong><br/>
                50 mg every 8 hours for 3 days.</li>
              <li class="dose child"><strong>For children 3&#8211;6 years</strong><br/>
                100 mg every 12 hours for 3 days.</li>
              <li class="dose child"><strong>For children 7&#8211;9 years</strong><br/>
                100 mg every 8 hours for 3 days.</li>
              <li class="dose child"><strong>For children 10&#8211;17 years</strong><br/>
                200&#8211;250 mg every 8 hours for 3 days.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Acute oral infections</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                200 mg every 8 hours for 3&#8211;7 days.</li>
              <li class="dose child"><strong>For children 1&#8211;2 years</strong><br/>
                50 mg every 8 hours for 3&#8211;7 days.</li>
              <li class="dose child"><strong>For children 3&#8211;6 years</strong><br/>
                100 mg every 12 hours for 3&#8211;7 days.</li>
              <li class="dose child"><strong>For children 7&#8211;9 years</strong><br/>
                100 mg every 8 hours for 3&#8211;7 days.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Surgical prophylaxis</span>,
            </h4>
            <p class="specificity"><span class="route">By intravenous infusion</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                400&#8211;500 mg, to be administered 2 hours before surgery, then 400&#8211;500 mg every 8 hours if required for up to 3 doses (in high-risk procedures).</li>
              <li class="dose adult"><strong>For adults </strong><br/>
                1 g, to be administered 2 hours before surgery, then 1 g every 8 hours if required for up to 3 doses (in high-risk procedures).</li>
              <li class="dose adult"><strong>For adults </strong><br/>
                500 mg, to be administered up to 30 minutes before the procedure (if rectal administration inappropriate), then 500 mg every 8 hours if required for up to 3 doses (in high-risk procedures).</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Invasive intestinal amoebiasis</span>,
                <span class="indication">Extra-intestinal amoebiasis (including liver abscess)</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                800 mg 3 times a day for 5 days in intestinal infection (for 5&#8211;10 days in extra-intestinal infection).</li>
              <li class="dose child"><strong>For children 1&#8211;2 years</strong><br/>
                200 mg 3 times a day for 5 days in intestinal infection (for 5&#8211;10 days in extra-intestinal infection).</li>
              <li class="dose child"><strong>For children 3&#8211;6 years</strong><br/>
                200 mg 4 times a day for 5 days in intestinal infection (for 5&#8211;10 days in extra-intestinal infection).</li>
              <li class="dose child"><strong>For children 7&#8211;9 years</strong><br/>
                400 mg 3 times a day for 5 days in intestinal infection (for 5&#8211;10 days in extra-intestinal infection).</li>
              <li class="dose child"><strong>For children 10&#8211;17 years</strong><br/>
                800 mg 3 times a day for 5 days in intestinal infection (for 5&#8211;10 days in extra-intestinal infection).</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Urogenital trichomoniasis</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                200 mg 3 times a day for 7 days, alternatively 400&#8211;500 mg twice daily for 5&#8211;7 days, alternatively 2 g for 1 dose.</li>
              <li class="dose child"><strong>For children 1&#8211;2 years</strong><br/>
                50 mg 3 times a day for 7 days.</li>
              <li class="dose child"><strong>For children 3&#8211;6 years</strong><br/>
                100 mg twice daily for 7 days.</li>
              <li class="dose child"><strong>For children 7&#8211;9 years</strong><br/>
                100 mg 3 times a day for 7 days.</li>
              <li class="dose child"><strong>For children 10&#8211;17 years</strong><br/>
                200 mg 3 times a day for 7 days, alternatively 400&#8211;500 mg twice daily for 5&#8211;7 days, alternatively 2 g for 1 dose.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Giardiasis</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                2 g once daily for 3 days, alternatively 400 mg 3 times a day for 5 days, alternatively 500 mg twice daily for 7&#8211;10 days.</li>
              <li class="dose child"><strong>For children 1&#8211;2 years</strong><br/>
                500 mg once daily for 3 days.</li>
              <li class="dose child"><strong>For children 3&#8211;6 years</strong><br/>
                600&#8211;800 mg once daily for 3 days.</li>
              <li class="dose child"><strong>For children 7&#8211;9 years</strong><br/>
                1 g once daily for 3 days.</li>
              <li class="dose child"><strong>For children 10&#8211;17 years</strong><br/>
                2 g once daily for 3 days, alternatively 400 mg 3 times a day for 5 days, alternatively 500 mg twice daily for 7&#8211;10 days.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Established case of tetanus</span>,
            </h4>
            <p class="specificity"><span class="route">By intravenous infusion</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                (consult product literature).</li>
            </ul>
          </section>
        </section>
        
        
        
        
        
      </section>


      <section class="tab-pane" id="drugAction">
        <h2>Drug action</h2>

            <section class="drugAction">
              <p>Metronidazole is an antimicrobial drug with high activity against anaerobic bacteria and protozoa.</p>
            </section>
      </section>

      <section class="tab-pane" id="pregnancy">
        <h2>Advice when patient is pregnant</h2>

            <section class="generalInformation">
              <h3 class="specificity">With <ph outputclass="route">systemic</ph> use</h3>
              <p>Manufacturer advises avoidance of high-dose regimens; use only if potential benefit outweighs risk.</p>
            </section>
      </section>

      <section class="tab-pane" id="hepaticImpairment">
        <h2>Advice regarding hepatic impairment</h2>

            <section class="doseAdjustments">
              <h3 class="specificity">With <ph outputclass="route">systemic</ph> use</h3>
              <p>In severe liver disease reduce total daily dose to one-third, and give once daily.</p>
            </section>
            <section class="generalInformation">
              <h3 class="specificity">With <ph outputclass="route">systemic</ph> use</h3>
              <p>Use with caution in hepatic encephalopathy.</p>
            </section>
      </section>



      <section class="tab-pane" id="sideEffects">
        <h2>Known side effects</h2>

        
          <h3>Specific side effects</h3>
              <p>
                <strong>veryRare:</strong> arthralgia, ataxia, darkening of urine, dizziness, drowsiness, erythema multiforme, headache, hepatitis, jaundice, leucopenia (on prolonged or intensive therapy), myalgia, pancreatitis, pancytopenia, peripheral neuropathy (on prolonged or intensive therapy), pruritus, psychotic disorders, rash, thrombocytopenia, transient epileptiform seizures (on prolonged or intensive therapy), visual disturbances,
              </p>
              <p>
                <strong>notKnown:</strong> anorexia, aseptic meningitis, furred tongue, gastro-intestinal disturbances, nausea, optic neuropathy, oral mucositis, taste disturbances, vomiting, skin irritation, abnormal vaginal discharge, local irritation, pelvic discomfort, vaginal candidiasis,
              </p>
        
        
      </section>

      <section class="tab-pane" id="directionsForAdministration">
        <h2>Directions for administration</h2>

            <section class="directionsForAdministration">
              <h3 class="specificity">With <ph outputclass="route">intravenous</ph> use</h3>
              <p>For <i>intravenous infusion</i>, give over 20&#8211;30 minutes.</p>
            </section>
      </section>

      <section class="tab-pane" id="patientAndCarerAdvice">
        <h2>Advice for patients and carers</h2>

            <section class="patientResources">
              <h3 class="specificity">In children</h3>
                <p class="title">Medicines for Children leaflet: Metronidazole for bacterial infections</p>
              <p>
            <xref format="html" href="http://www.medicinesforchildren.org.uk/metronidazole-for-bacterial-infections">www.medicinesforchildren.org.uk/metronidazole-for-bacterial-infections</xref>
            </p>
            </section>
      </section>



      <section class="tab-pane" id="cautions">
        <h2>Cautions regarding administration</h2>

        <ul>
          <li>
              <strong>With topical use:</strong>
            avoid exposure to strong sunlight or UV light
          </li>
          <li>
              <strong>With vaginal use:</strong>
            avoid intravaginal preparations (particularly those that require the use of an applicator) in young girls who are not sexually active, unless there is no alternative in children
          </li>
          <li>
              <strong>With vaginal use:</strong>
            not recommended during menstruation
          </li>
          <li>
              <strong>With vaginal use:</strong>
            some systemic absorption may occur with vaginal gel
          </li>
        </ul>
      </section>


      <section class="tab-pane" id="monitoringRequirements">
        <h2>Monitoring requirements</h2>

        
          <h3>Patient parameters</h3>
        
            <section class="patientParameters">
              <h3 class="specificity">With <ph outputclass="route">systemic</ph> use</h3>
              <p>Clinical and laboratory monitoring advised if treatment exceeds 10 days.</p>
            </section>
      </section>

      <section class="tab-pane" id="unlicensedUse">
        <h2>Unlicensed use</h2>

            <section class="unlicensedUse">
              <h3 class="specificity">With <ph outputclass="route">vaginal</ph> use in children</h3>
              <p>Metronidazole vaginal gel not licensed for use in children under 18 years.</p>
            </section>
            <section class="unlicensedUse">
              <h3 class="specificity">With <ph outputclass="route">systemic</ph> use in adults</h3>
              <p>Metronidazole doses in the BNF may differ from those in product literature.</p>
            </section>
      </section>

      <section class="tab-pane" id="prescribingAndDispensingInformation">
        <h2>Information regarding prescribing and dispensing</h2>

            <section class="prescribingAndDispensingInformation">
              <h3 class="specificity">With <ph outputclass="route">systemic</ph> use</h3>
              <p>Metronidazole is well absorbed orally and the intravenous route is normally reserved for severe infections. Metronidazole by the rectal route is an effective alternative to the intravenous route when oral administration is not possible.</p>
            </section>
      </section>






      <section class="tab-pane" id="professionSpecificInformation">
        <h2>Profession specific information</h2>

          <h3>Dental practitioners</h3>
        
            <section class="dentalPractitionersFormulary">
              <p>Metronidazole Tablets may be prescribed.</p><p>Metronidazole Oral Suspension may be prescribed.</p>
            </section>
      </section>



      <section class="tab-pane" id="medicinalForms">
        <h2>Prepared medicinal forms of METRONIDAZOLE</h2>


            <section class="licensingVariationStatement">
              <p>There can be variation in the licensing of different medicines containing the same drug.</p>
            </section>
        
          <strong>Forms available from special-order manufacturers include: </strong>
            oral suspension,
            oral solution,
            gel,
            cream,

            <div id="PHP74867"><a href="../medicinalForm/PHP74867.html" data-target="#PHP74867" data-action="load">Tablet</a></div>
            <div id="PHP74915"><a href="../medicinalForm/PHP74915.html" data-target="#PHP74915" data-action="load">Oral suspension</a></div>
            <div id="PHP74872"><a href="../medicinalForm/PHP74872.html" data-target="#PHP74872" data-action="load">Infusion</a></div>
            <div id="PHP74878"><a href="../medicinalForm/PHP74878.html" data-target="#PHP74878" data-action="load">Suppository</a></div>
            <div id="PHP74897"><a href="../medicinalForm/PHP74897.html" data-target="#PHP74897" data-action="load">Cream</a></div>
            <div id="PHP74921"><a href="../medicinalForm/PHP74921.html" data-target="#PHP74921" data-action="load">Gel</a></div>
            <div id="PHP74926"><a href="../medicinalForm/PHP74926.html" data-target="#PHP74926" data-action="load">Vaginal gel</a></div>
      </section>
    </div>
  </div>

  <script src="http://mattonfoot.github.io/NICE.UI/scripts/vendor/jquery.js"></script>
  <script src="http://cdn.nice.org.uk/V3/Scripts/twitter.bootstrap.js"></script>
  <script src="/content/scripts/NICE.RemoteLoad.js"></script>
</html>
